Clinical trials: Lenalidomide, completed
Multiple Myeloma
Study of the Efficacy and Safety of RsqVD Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma
This study aims to evaluate the overall response rate after 4 cycles and the best response to induction therapy with combination of lenalidomide, subcutaneous bortezomib, and dexamethasone (RsqVD) in patients with newly diagnosed…
- Trial name
- NCT02219178
- Testing
- lenalidomide, Subcutaneous bortezomib, Dexamethasone
- Where
- 8 sites in Ireland
- Volunteers
- 42 people
- Sponsor
- Cancer Trials Ireland
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Lenalidomide and Rituximab as Treatment of Chronic Lymphocytic Leukemia
The goal of this clinical research study is to learn if the combination of lenalidomide and rituximab can help to control Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) in patients who have already…
- Trial name
- NCT00759603
- Testing
- Lenalidomide, Rituximab
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- M.D. Anderson Cancer Center